Nurse Practitioner, Family · South Miami, FL
NPI
1831442607
Since 2012
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7900 SW 57th Ave Ste 21
South Miami, FL, 33143
Phone (305) 662-3984
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.1M
2,369 prescriptions
Company payments, 2025
$3,768
From 13 companies
Medicare prescription drug claims, 2024
In 2024, the drug Darlena Banas prescribed most often to Medicare patients was Sevelamer Carbonate, with 387 prescriptions and refills. In total Darlena Banas wrote 2,369 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sevelamer Carbonate Generic | 387 | 622 | 110 | $59K |
| Velphoro Sucroferric Oxyhydroxide | 225 | 269 | 59 | $593K |
| Nifedipine Er Nifedipine | 162 | 398 | 68 | $4,982 |
| Veltassa Patiromer Calcium Sorbitex | 128 | 171 | 43 | $129K |
| Losartan Potassium Generic | 99 | 267 | 37 | $1,019 |
| Carvedilol Generic | 99 | 255 | 40 | $684 |
| Lokelma Sodium Zirconium Cyclosilicate | 86 | 130 | 28 | $71K |
| Bumetanide Generic | 77 | 170 | 32 | $3,665 |
| Amlodipine Besylate Generic | 77 | 193 | 30 | $378 |
| Midodrine Hcl Generic | 75 | 156 | 28 | $8,565 |
| Doxazosin Mesylate Generic | 73 | 130 | 15 | $1,099 |
| Calcium Acetate Generic | 59 | 117 | 17 | $6,780 |
| Potassium Chloride Generic | 45 | 80 | Under 11 | $1,078 |
| Auryxia Ferric Citrate | 44 | 56 | 11 | $64K |
| Hydralazine Hcl Generic | 44 | 118 | 19 | $874 |
Brand drugs: 565 claims; generic drugs: 1,804 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Darlena Banas $3,768 ($3,768 in general payments such as food, travel and fees) from 13 companies. The largest payer was Fresenius USA Marketing, Inc. with $2,129.
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 7 | $2,129 |
| Vifor Pharma, Inc. | 7 | $494 |
| Ardelyx, Inc. ARDX | 8 | $244 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $129 |
| Calliditas Therapeutics US Inc. | 1 | $126 |
| Akebia Therapeutics Inc AKBA | 1 | $122 |
| GlaxoSmithKline, LLC. GSK | 1 | $122 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $118 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $104 |
| Genzyme Corporation SNY | 1 | $94.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.